Related Experiment Video
Updated: Dec 13, 2025

A Rat Graft Rejection Model of Intestinal Transplantation with Exteriorized Ileostomy for Longitudinal Prognosis Assessment
Published on: June 10, 2025
Steroid-Refractory Protein-Losing Enteropathy with Gastrointestinal Bleeding in a Patient with Fontan Circulation
Yoichi Iwamoto1, Shun Matsumura1, Hirotaka Ishido1
1Department of Pediatrics, Saitama Medical Center, Saitama Medical University.
Insights
Protein-losing enteropathy (PLE) after Fontan surgery can cause gastrointestinal bleeding. This case suggests protein loss may be linked to bleeding, highlighting a potential treatment target for these complex cases.
Area of Science:
- Cardiology
- Gastroenterology
- Pediatric Surgery
Background:
- Protein-losing enteropathy (PLE) is a significant complication following the Fontan operation.
- Concurrent gastrointestinal bleeding occurs in some PLE patients, complicating management.
- Effective treatment strategies for post-Fontan PLE with gastrointestinal bleeding remain undefined.
Observation:
- A 7-year-old patient presented with steroid-refractory post-Fontan PLE.
- This patient also experienced concurrent gastrointestinal bleeding.
- The coexistence of PLE and gastrointestinal bleeding prompted further investigation into their relationship.
Findings:
- The case suggests a potential association between protein loss and gastrointestinal bleeding in post-Fontan PLE.
- This challenges the notion that these conditions might coexist independently.
- A literature review was conducted to contextualize these findings.
Implications:
- Understanding the link between protein loss and bleeding could lead to targeted therapeutic approaches.
- This may improve outcomes for Fontan patients suffering from PLE and gastrointestinal bleeding.
- Further research is warranted to confirm this pathogenesis and develop effective treatments.
Abstract:
Protein-losing enteropathy (PLE) is one of the major complications after a Fontan operation. Some PLE patients suffer from concurrent gastrointestinal bleeding. An effective treatment regimen for such patients has not been established yet. Further, it remains unknown whether PLE and gastrointestinal bleeding coexist independently, or protein losing is associated with gastrointestinal bleeding. We report a 7-year-old steroid-refractory post-Fontan PLE case suggesting the latter pathogenesis together with a literature review.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy

